Abstract
BackgroundLannea egregia leaf has been used locally for the management of diseases with limited scientific support. Hence, the cardiomyopathy protective ability of an alkaloid-rich extract of L. egregia leaf in streptozotocin-induced type 2 diabetic rats was investigated in this study. A L. egregia leaf alkaloid-rich extract was obtained using a standard procedure. Streptozotocin was injected into the experimental animals intraperitoneal at a dose of 45 mg/kg body weight to induce type 2 diabetes mellitus, prior to this, the animals were given 20 % (w/v) fructose for one week. Thus, the animals were grouped into five (n = 8), comprising normal control (NC), diabetic control (DC), diabetic rats treated with low (50 mg/kg body weight) and high (100 mg/kg body weight) doses of L. egregia alkaloid-rich leaf extracts (i.e., LEL and LEH, respectively), and 200 mg/kg body weight metformin (MET). The animals were sacrificed on the 21st day, and blood and hearts were harvested and used for the determination of serum lipid profiles, atherogenic indices, oxidative stress biomarkers, ATPase activities, cardiac enzyme activities, creatinine kinase-MB, cardiac troponin, cytokines, N-terminal pro-B-type brain natriuretic peptide (NT-pro BNP) and histology examination. ResultsThe results revealed that diabetic rats treated with LEL, LEH, and MET significantly (p < 0.05) reduced their fasting blood glucose levels, improved their serum lipid profile, and decreased their cardio-risk ratio, atherogenic index of plasma, atherogenic coefficient, and atherosclerosis index. In addition, diabetic treated with on LEL, LEH, and MET significantly (p < 0.05) ameliorated oxidative stress biomarkers, increased selected ATPase activities, increased specific cardiac enzyme activities, and decreased serum creatine kinase-MB, serum cardiac troponin I and T, as well as cytokines and NT-pro BNP in diabetic rats. These were supported by the histology examination by improving myocardial degeneration in diabetic rats administered LEL, LEH, and MET. ConclusionHence, it can be presumed that alkaloid-rich extracts obtained from L. egregia leaves could be beneficial in ameliorating diabetic cardiomyopathy conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
